Lindbrook Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Lindbrook Capital’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-162	Closed	-$3K	–	2861
2023 Q3	$3K	Buy	+162	New	+$1.83K	﹤0.01%	1982
2022 Q4	–	Sell	-15	Closed	–	–	3054
2022 Q3	$0	Buy	+15	New	+$242	﹤0.01%	2988

Lindbrook Capital's ICPT Position: Q4 2023 in Review

Lindbrook Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 162 shares — an estimated $3K sold.

Lindbrook Capital first reported a position in ICPT in Q3 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Lindbrook Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Lindbrook Capital sold 162 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3K.
Lindbrook Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
Lindbrook Capital's Intercept Pharmaceuticals, Inc. position peaked at $3K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.